| Bioactivity | LCMV-derived p13 epitope is a biological active peptide. (An H-2Db restricted epitope, this peptide is amino acids 61 to 80 fragment of the lymphocytic choriomeningitis virus (LCMV) pre-glycoprotein polyprotein GP complex. LCMV has been routinely used for the study of adaptive immune responses to viral infection.) |
| Name | LCMV-derived p13 epitope |
| CAS | 474105-11-8 |
| Sequence | Gly-Leu-Asn-Gly-Pro-Asp-Ile-Tyr-Lys-Gly-Val-Tyr-Gln-Phe-Lys-Ser-Val-Glu-Phe-Asp |
| Shortening | GLNGPDIYKGVYQFKSVEFD |
| Formula | C106H154N24O32 |
| Molar Mass | 2276.50 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
LCMV-derived p13 epitope
CAS: 474105-11-8 F: C106H154N24O32 W: 2276.50
LCMV-derived p13 epitope is a biological active peptide. (An H-2Db restricted epitope, this peptide is amino acids 61 to
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.